has expanded its recall of Clonazepam Orally Disintegrating Tablets (C-IV), according to the U.S. Food and Drug Administration. The recalled drugs were mislabeled with the incorrect strength on ...
(OTCQX: NDOI) (“Endo”) announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, USP ...
is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to potential product carton strength mislabeling. Specifically, Endo's ...